WDR12 and cancer: Furthermore, it was discovered that TMB, MSI, and immunoregulators are associated with WDR12 expression in a subset of human cancers; therefore, these results potentially propose WDR12 as a prognostic biomarker of patients’ responsiveness to immunotherapy and a possible cancer treatment target.